Hernán Miguel A
BMJ. 2018 Feb 1;360:k182. doi: 10.1136/bmj.k182.
When using observational data, quantifying the effect of treatment duration on survival outcomes is not straightforward because only people who live for a long time can receive treatment for a long time. This problem doesn’t apply to randomised trials because people are classified based on the treatment duration they are assigned, rather than the treatment duration that they achieve. This approach accepts that dead people do not deviate from their assigned treatment strategy. By transferring this insight to the analysis of observational data, we can follow three steps to estimate the effect of treatment duration from observational data without the bias of naive comparisons between long term and short term users. The first step is cloning people to assign them to multiple treatment strategies. The second step is censoring clones when they deviate from their assigned treatment strategy. The third step is performing inverse probability weighting to adjust for the potential selection bias introduced by censoring. The procedure can be used to compare any treatment strategies that are sustained over time. Cloning, censoring, and weighting eliminates immortal time bias in the estimates of absolute and relative risk, which helps researchers focus their attention on other biases that may be present in observational analyses and are not so easily eliminated.
在使用观察性数据时,量化治疗持续时间对生存结果的影响并非易事,因为只有存活时间长的人才能接受长时间的治疗。这个问题不适用于随机试验,因为人们是根据分配给他们的治疗持续时间进行分类的,而不是根据他们实际接受的治疗持续时间。这种方法假定死亡的人不会偏离他们被分配的治疗策略。通过将这一见解应用于观察性数据的分析,我们可以遵循三个步骤,从观察性数据中估计治疗持续时间的影响,而不会出现长期和短期使用者之间简单比较所产生的偏差。第一步是克隆个体,将他们分配到多种治疗策略中。第二步是当克隆个体偏离其分配的治疗策略时进行删失。第三步是进行逆概率加权,以调整删失所引入的潜在选择偏差。该程序可用于比较任何随时间持续的治疗策略。克隆、删失和加权消除了绝对风险和相对风险估计中的不朽时间偏差,这有助于研究人员将注意力集中在观察性分析中可能存在且不太容易消除的其他偏差上。